Henry Schein, Inc. (LON:0L3C)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 6.25B |
| Revenue (ttm) | 9.79B |
| Net Income (ttm) | 314.40M |
| Shares Out | n/a |
| EPS (ttm) | 2.48 |
| PE Ratio | 19.87 |
| Forward PE | 13.49 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2 |
| Average Volume | 1,015 |
| Open | 67.85 |
| Previous Close | 68.48 |
| Day's Range | 67.85 - 67.85 |
| 52-Week Range | 60.80 - 82.31 |
| Beta | 0.87 |
| RSI | 38.96 |
| Earnings Date | Aug 5, 2025 |
About Henry Schein
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The company offers dental merchandise, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, and PPE products; dental equipment, such as dental chair... [Read more]
Financial Performance
In 2024, Henry Schein's revenue was $12.67 billion, an increase of 2.71% compared to the previous year's $12.34 billion. Earnings were $390.00 million, a decrease of -6.25%.
Financial numbers in USD Financial StatementsNews
Henry Schein to Webcast Second Quarter 2025 Conference Call on Tuesday, August 5, 2025, at 8:00 a.m. ET
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will...
IntelePeer Joins Henry Schein One Academic Partner Program
DANIA BEACH, Fla.--(BUSINESS WIRE)--IntelePeer, a leading, end-to-end conversational AI platform provider for Dental Service Organizations (DSOs), today announced that it is now an authorized integrat...
Stanley M. Bergman to Retire as Henry Schein's Chief Executive Officer at the End of 2025
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that Stanley...
This Procter & Gamble Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag...
What Does the Market Think About Henry Schein?
Henry Schein's (NYSE: HSIC) short percent of float has risen 19.87% since its last report. The company recently reported that it has 7.89 million shares sold short , which is 7.24% of all regular sha...
Updated: Henry Schein to Participate in Upcoming Investor Conference in June
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will prese...
Henry Schein One Unveils The Catalyst Index, a Look into Dentistry's Top 10%
AMERICAN FORK, Utah--(BUSINESS WIRE)--Henry Schein One today announced the launch of The 2025 Catalyst Index, its exclusive report offering dental practices an unparalleled view into the strategies tr...
Henry Schein Post Earnings Review
Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced the successf...
Henry Schein to Participate in Upcoming Investor Conference in June
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will prese...
These Analysts Lower Their Forecasts On Henry Schein Following Q1 Results
Henry Schein Inc . (NASDAQ: HSIC) reported mixed results for its first-quarter on Monday . The company posted adjusted EPS of $1.15, up 4.5% year over year, beat the consensus of $1.11. Sales were $3...
These Analysts Lower Their Forecasts On Henry Schein Following Q1 Results
Henry Schein Inc. HSIC reported mixed results for its first-quarter on Monday.
Henry Schein to Participate in Upcoming Investor Conferences in May
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will prese...
Henry Schein, Inc. (HSIC) Q1 2025 Earnings Call Transcript
Henry Schein, Inc. 2025 Q1 - Results - Earnings Call Presentation
The following slide deck was published by Henry Schein, Inc.
Earnings Summary: Henry Schein (HSIC) reports higher Q1 2025 profit
Henry Schein, Inc. (Nasdaq: HSIC), a provider of healthcare solutions to office-based dental and medical practitioners, Monday reported an increase in net income for the first quarter of 2025. At $3.2...
Henry Schein's Reports Mixed Bag Q1 Earnings, CEO Confident In Business Fundamentals
Henry Schein Inc. (NYSE: HSIC) reported on Monday that its first-quarter adjusted EPS of $1.15, up 4.5% year over year, beat the consensus of $1.11 . Sales were $3.17 billion, missing the consensus o...
Henry Schein misses quarterly revenue estimates on weak demand for dental products
Medical supplies distributor Henry Schein Inc on Monday missed first-quarter revenue estimates, hurt by muted demand for its dental products amid rising inflation.
Henry Schein Non-GAAP EPS of $1.15 beats by $0.04, revenue of $3.17B misses by $60M
Henry Schein Reports First Quarter 2025 Financial Results
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported financial res...
Earnings Scheduled For May 5, 2025
Companies Reporting Before The Bell • Recursion Pharmaceuticals (NASDAQ: RXRX) is likely to report quarterly loss at $0.52 per share on revenue of $18.08 million. • Freshpet (NASDAQ: FRPT) is estima...
Henry Schein Q1 2025 Earnings Preview
Henry Schein Medical Announces Winner of Its 2025 Rising Star Award
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), announced today that Ian Jeffer, MS, ATC, LAT, Head Athletic Trainer at Desert Ri...
Henry Schein to Webcast First Quarter 2025 Conference Call on Monday, May 5th, 2025, at 8:00 a.m. ET
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will...
Henry Schein Received Validation of Net-Zero Science-Based Targets
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Sci...